Axe Compute (AGPU) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
2 Jul, 2026Company overview and business model
Provides high-performance computing infrastructure for AI workloads by sourcing and deploying large-scale GPU capacity for enterprise clients under long-term service agreements.
Offers two main customer models: custom infrastructure deployments and rapid access to third-party GPU compute resources.
Maintains a legacy oncology drug discovery business, but is exploring strategic alternatives for this segment.
Holds a significant reserve of ATH tokens, the native utility token of the Aethir decentralized GPU network, to secure immediate compute access.
Financial performance and metrics
As of July 1, 2026, the market value of common stock held by non-affiliates is $79.8 million, based on 11,054,024 shares at $7.22 per share.
Strategic Compute Reserve includes approximately 6.166 billion ATH tokens valued at $26.8 million as of July 1, 2026.
Entered a 36-month, $260 million enterprise infrastructure contract in April 2026 for a dedicated cluster of 2,304 NVIDIA B300 GPUs.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for general corporate purposes, working capital, expanding compute infrastructure, and growing the Strategic Compute Reserve.
May allocate funds for capital expenditures, IP or technology acquisitions, and potential investments in complementary businesses.
Management has broad discretion over allocation and timing of expenditures.
Latest events from Axe Compute
- Revenue up, net loss widens; major contracts and ATH volatility shape outlook.AGPU
Q2 2026 - Offering up to $1B in securities to scale AI-focused GPU infrastructure and digital asset reserves.AGPU
Registration filing - AI infrastructure provider seeks to raise $1B for GPU expansion and strategic reserves.AGPU
Registration filing - $260M contract and $4.3B pipeline drive AI compute pivot; Q1 net loss $7.7M, revenue $35K.AGPU
Q1 2026 - Raised $343.5M, secured $12M in contracts, and ended 2025 with a $233M net loss.AGPU
Q4 2025 - Registering 1.98M shares for resale; proceeds from warrant exercises fund operations.AGPU
Registration Filing - AI-driven oncology firm shifts capital to Aethir tokens, heightening volatility and regulatory risk.AGPU
Registration Filing - AI oncology and ATH-focused treasury strategy drive growth amid high digital asset risk.AGPU
Registration Filing - Q2 2024 saw a $3.2M loss, cost cuts, and new AI/ML partnerships amid going concern risks.AGPU
Q2 2024